Literature DB >> 2026739

Thyroid hormones and bone mass.

D T Baran, L E Braverman.   

Abstract

Mesh：

Substances：

Year:  1991        PMID： 2026739     DOI： 10.1210/jcem-72-6-1182

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN： 0021-972X            Impact factor:   5.958


× No keyword cloud information.
  8 in total

1.  Levothyroxine suppressive therapy: harmful and useless or harmless and useful?

Authors:  L Bartalena; A Pinchera
Journal:  J Endocrinol Invest       Date:  1994-09       Impact factor: 4.256

2.  Bone turnover in hyperthyroidism before and after thyrostatic management.

Authors:  G C Isaia; C Roggia; D Gola; M D Stefano; G Gallone; G Aimo; P Ardissone; M Mussetta
Journal:  J Endocrinol Invest       Date:  2000-12       Impact factor: 4.256

Review 3.  Adverse effects of thyroid hormone preparations and antithyroid drugs.

Authors:  L Bartalena; F Bogazzi; E Martino
Journal:  Drug Saf       Date:  1996-07       Impact factor: 5.606

Review 4.  Subclinical hyperthyroidism: to treat or not to treat?

Authors:  E H Hoogendoorn; M den Heijer; A P J van Dijk; A R Hermus
Journal:  Postgrad Med J       Date:  2004-07       Impact factor: 2.401

5.  Spinal bone mass after long-term treatment with L-thyroxine in postmenopausal women with thyroid cancer and chronic lymphocytic thyroiditis.

Authors:  F Hawkins; D Rigopoulou; K Papapietro; M B Lopez
Journal:  Calcif Tissue Int       Date:  1994-01       Impact factor: 4.333

6.  Bone demineralization in postmenopausal women: role of anamnestic risk factors.

Authors:  Sandro La Vignera; Rosita A Condorelli; Enzo Vicari; Chiara Nicoletti; Aldo E Calogero
Journal:  Int J Endocrinol       Date:  2012-07-26       Impact factor: 3.257

7.  Calcitonin, the forgotten hormone: does it deserve to be forgotten?

Authors:  Arnold J Felsenfeld; Barton S Levine
Journal:  Clin Kidney J       Date:  2015-03-20

Review 8.  Is calcitonin an important physiological substance?

Authors:  Philip F Hirsch; Hans Baruch
Journal:  Endocrine       Date:  2003-08       Impact factor: 3.925
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.